Market overview
The Intravascular Catheters Market is entering a strong growth phase as healthcare systems increasingly adopt minimally invasive vascular-access technologies for diagnosis, treatment, medication delivery, oncology care, renal disease management, and other hospital-based procedures. According to the latest market assessment by Maximize Market Research, the global Intravascular Catheters Market was valued at USD 9.39 billion in 2023 and is projected to reach approximately USD 19.99 billion by 2030, expanding at a CAGR of 11.4% from 2024 to 2030.
Market Estimation, Growth Drivers and Opportunities
The market's expansion is supported by the increasing incidence of chronic and serious diseases, including cancer, renal disorders, infectious diseases and conditions requiring hospitalization and repeated vascular access. The growing number of patients undergoing intravenous medication, fluid administration, diagnostic procedures and minimally invasive interventions is creating sustained demand for intravascular catheter systems. MMR also identifies the rising incidence of brain injuries and other diseases as important contributors to catheter utilization.
Technological advancement is another important growth driver. New-generation catheter systems are being designed to improve ease of insertion, reduce patient discomfort, enhance safety and minimize complications associated with vascular access. Short peripheral intravenous catheters (PIVCs), in particular, are increasingly used in minimally invasive procedures, while advanced catheter designs are helping clinicians access difficult anatomical locations. The expansion of ambulatory surgical centers and catheterization laboratories is also creating additional opportunities for catheter manufacturers.
The opportunity landscape extends beyond conventional hospital applications. Growth in home-based care, chronic disease management and long-term treatment is likely to encourage demand for safer and more patient-friendly vascular-access systems. Manufacturers that invest in antimicrobial protection, closed-system designs, safety-engineered technologies and catheter materials that improve durability and biocompatibility can capture emerging opportunities.
U.S. Market Trends and Investment in 2025
The United States remained a particularly important market within North America, supported by advanced healthcare infrastructure, a large installed base of hospitals and high adoption of medical technologies. A significant 2025 development came from Becton, Dickinson and Company (BD), which announced plans for more than USD 30 million of investment in 2025 to expand IV-line manufacturing capacity at its Utah facility. The investment followed more than USD 2 million in 2024 improvements that increased IV-catheter output by more than 40 million units annually. BD stated that the expansion would support continued growth in catheter solutions and strengthen U.S. medical-device supply resilience. (Becton, Dickinson and Company)
The U.S. regulatory environment also demonstrated continued innovation in vascular access during 2025. The FDA cleared BD's Insyte Autoguard shielded IV catheter family through the 510(k) pathway in June 2025. Access Vascular also received FDA clearance for its HydroPICC long-term catheter products in 2025, demonstrating continued development of advanced materials and vascular-access designs. Terumo additionally received U.S. 510(k) clearance in December 2025 for its SURFLO Hybria Closed System Safety IV Catheter. (FDA Access Data)
Request To Free Sample of This Strategic Report ➤https://www.maximizemarketresearch.com/request-sample/90628/
Market Segmentation – Leading Market Areas
Intravascular Catheters Market Segmentation
By Product
Short Peripheral Intravascular Catheters (PIVC)
Integrated/Closed Peripheral Intravascular Catheters (PIVC)
By Application
Oncology
Gastroenterology
Renal Disease
Infectious Diseases
Other Diseases
By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Homecare Settings
Others
By Region
North America
Europe
Asia Pacific
Middle East & Africa
South America
Competitive Analysis
The global market is characterized by competition among established medical-device companies focusing on catheter safety, infection prevention, manufacturing capacity and minimally invasive technologies. Five prominent companies from the MMR-listed competitive landscape are Medtronic, B. Braun Melsungen AG, Boston Scientific Corporation, Becton, Dickinson and Company (BD), and Teleflex. MMR's report specifically includes these companies among its key players and evaluates competition through market presence, product enhancements, R&D investment and competitive positioning. (MAXIMIZE MARKET RESEARCH)
BD is strengthening its position through U.S. manufacturing investment and catheter-production expansion. Its 2025 investment program is expected to increase capacity for IV lines while supporting supply-chain resilience. Its Insyte Autoguard and Nexiva product developments also demonstrate continued emphasis on safety-engineered and closed IV catheter technologies. (Becton, Dickinson and Company)
Medtronic remains an important global medical-technology player with a broad cardiovascular and minimally invasive portfolio. Its continued investment in catheter-based interventions and advanced navigation technologies supports the wider movement toward less invasive procedures.
B. Braun maintains a strong position in vascular access and infusion therapy, with emphasis on safety, infection prevention and catheter technologies designed to improve clinical workflow. Its broad hospital presence provides an important competitive advantage as healthcare providers prioritize safer vascular access.
Boston Scientific continues to expand its catheter-based cardiovascular intervention portfolio. The company's focus on electrophysiology, vascular intervention and minimally invasive cardiovascular procedures supports long-term demand for sophisticated catheter technologies.
Teleflex strengthened its vascular-access position in 2025 through a contract with Vizient covering short-term central venous catheters. Its Arrow vascular-access portfolio emphasizes protection against complications including infection, thrombosis and tip malposition. Teleflex also highlights antimicrobial protection in its Arrowg+ard Blue Plus CVCs, supporting the market's shift toward infection-prevention technologies. (Teleflex Investors)
Regional Analysis
United States: The U.S. is a major contributor to North America's leading position due to advanced hospitals, high healthcare expenditure, strong medical-device manufacturing capabilities and rapid adoption of new catheter technologies. Investments by manufacturers such as BD are further strengthening domestic production capacity. FDA clearances for new catheter systems during 2025 demonstrate continued product innovation and regulatory activity. (FDA Access Data)
United Kingdom: The UK benefits from established healthcare infrastructure and demand for minimally invasive procedures. Adoption of safer catheter technologies and efforts to reduce healthcare-associated infections can support market development.
Germany: Germany represents an important European market because of its advanced hospital infrastructure, established medical-device manufacturing base and strong demand for high-quality vascular-access technologies.
France: France's developed healthcare system and increasing use of minimally invasive treatment approaches create opportunities for catheter manufacturers, particularly in hospital and specialist-care environments.
Japan: Japan's aging population and sophisticated healthcare infrastructure provide a favorable environment for vascular-access products. Increasing demand for hospital treatment and chronic disease management can support catheter adoption.
China: China's expanding healthcare infrastructure, growing hospital capacity and increasing access to advanced medical procedures create substantial long-term opportunities for intravascular catheter manufacturers.
Request To Free Sample of This Strategic Report ➤https://www.maximizemarketresearch.com/request-sample/90628/
Intravascular Catheter Market Key Players
1. Medtronic
2. Vitality Medical
3. B.Braun
4. Melsungen
5. Coloplast
6. Boston Scientific Corporation
7. Koninklijke Philips N.V
8. Abbott
9. Medtronic Plc
10. Braun Melsungen Ag
11. Becton
12. Dickinson
13. Terumo Medical Corporation
14. Lumend Corporation
15. Covidien Ag
16. Acist Medical Systems
17. Cook Medical Inc.
18. Getinge AB
19. Biotronic SE & CO.KG
20. Biosense Webster Inc.
21. Cordis
Conclusion
The global Intravascular Catheters Market is positioned for significant expansion, with MMR forecasting growth from USD 9.39 billion in 2023 to nearly USD 19.99 billion by 2030 at an 11.4% CAGR. (MAXIMIZE MARKET RESEARCH) The strongest opportunities are likely to arise from the increasing prevalence of chronic diseases, higher hospital admissions, expansion of minimally invasive procedures, growth of ambulatory care and homecare, and demand for safer vascular-access solutions.
In our view, infection prevention, safety-engineered catheter systems, closed IV technologies, improved catheter materials and higher manufacturing capacity will be among the most influential factors shaping future market growth. Companies that combine clinical safety with easier insertion, reduced complications, antimicrobial protection and efficient manufacturing are likely to gain a competitive advantage. The substantial U.S. investment and continued FDA clearances seen in 2025 also demonstrate that innovation and supply-chain resilience will remain critical priorities for the industry.
About Maximize Market Research
Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting company that provides reliable, data-focused, and practical business insights. The firm serves a wide range of industries, including healthcare, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. Through market forecasts, competitive analysis, strategic consulting, and industry impact assessments, MMR helps organizations understand changing market conditions, identify growth opportunities, and make informed business decisions for long-term success.
Contact Us
Maximize Market Research Pvt. Ltd.
2nd Floor, Navale IT Park Phase 3
Pune Bangalore Highway, Narhe
Pune, Maharashtra 411041, India
Phone: +91 9607365656
Email: sales@maximizemarketresearch.com
